Strategic Partnerships Jaeb collaborates with pharma and biotech partners, as seen in the Alimera Sciences partnership supporting the DRCR Retina Network, highlighting a strong industry-facing role. This multi-center trial coordination presents sales opportunities for scalable trial management systems, robust data capture, site management, and analytics platforms for research networks and sponsors.

Virtual Care Momentum Grants and partnerships focused on virtual clinics and remote diabetes care indicate a market for telemedicine platforms, remote CGM onboarding and support, digital coaching, and patient engagement analytics to measure clinical and psychosocial outcomes in diabetes research.

Cloud and Security A tech stack centered on Microsoft Azure, Docker, Cloudways and security headers suggests readiness for cloud-native solutions and secure research applications. Opportunities exist to offer cloud modernization, containerization, application security hardening, monitoring, and compliance services to protect sensitive trial and patient data.

Grant-Driven Innovation Philanthropic funding and grant-supported initiatives imply potential for grant management, budgeting and forecasting tools, donor reporting, and impact-tracking dashboards to streamline philanthropy partnerships and program evaluations within research initiatives.

Growth and Expansion With a mid-sized profile of 51-200 employees and substantial revenue, Jaeb is well-positioned to expand contract research capabilities beyond eye disorders and type 1 diabetes, exploring broader multi-center trials, data analytics services, and epidemiologic research support to accelerate future studies.